SCHEMBL15068367

SCHEMBL15068367

CCCCOC(=O)Cc1cccc2c1COC(C)(C)O2

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 4/20 0.39
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
TSHR P16473 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HSD17B10 Q99714 1/20 0.35
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ELANE P08246 1/20 0.34
MIF P14174 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15068402 0.81 MTNR1A (0.39) L3MBTL1TSHRMEN1KMT2AALDH1A1
SCHEMBL18600542 0.79 AKR1B1 (0.39) TDP1KMT2AALDH1A1KDM4E
SCHEMBL28366194 0.71 TSHR (0.51) TDP1L3MBTL1TSHRMEN1KMT2A
SCHEMBL15160348 0.71 ALDH1A1 (0.35) KMT2AALDH1A1
SCHEMBL28362405 0.71 TSHR (0.54) TDP1L3MBTL1TSHRMEN1KMT2A
SCHEMBL28137294 0.71 ALDH1A1 (0.52) TDP1L3MBTL1TSHRMEN1KMT2A
SCHEMBL28366032 0.70 TSHR (0.53) TDP1L3MBTL1TSHRMEN1KMT2A
SCHEMBL28580608 0.69 NPSR1 (0.60) CNR2TDP1L3MBTL1TSHRMEN1
SCHEMBL2422452 0.69 TDP1 (0.47) TDP1L3MBTL1TSHRMEN1KMT2A
SCHEMBL20766473 0.69 CCR8 (0.45) KMT2AALDH1A1KDM4ELMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2797416-A1 SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION Global Blood Therapeutics, Inc. (US) 2014-11-05 EP disclosed
WO-2013102142-A1 SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION GLOBAL BLOOD THERAPEUTICS, INC. (US) 2013-07-04 WO disclosed